ZEBETA Drug Patent Profile
✉ Email this page to a colleague
When do Zebeta patents expire, and what generic alternatives are available?
Zebeta is a drug marketed by Teva Womens and is included in one NDA.
The generic ingredient in ZEBETA is bisoprolol fumarate. There are twelve drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the bisoprolol fumarate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zebeta
A generic version of ZEBETA was approved as bisoprolol fumarate by RUBICON on November 16th, 2000.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZEBETA?
- What are the global sales for ZEBETA?
- What is Average Wholesale Price for ZEBETA?
Summary for ZEBETA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 212 |
Clinical Trials: | 3 |
Patent Applications: | 4,421 |
DailyMed Link: | ZEBETA at DailyMed |
Recent Clinical Trials for ZEBETA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Heart Center BH Tuzla | Early Phase 1 |
IPCA Laboratories Ltd. | Phase 1 |
US Patents and Regulatory Information for ZEBETA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Womens | ZEBETA | bisoprolol fumarate | TABLET;ORAL | 019982-002 | Jul 31, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva Womens | ZEBETA | bisoprolol fumarate | TABLET;ORAL | 019982-001 | Jul 31, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZEBETA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Teva Womens | ZEBETA | bisoprolol fumarate | TABLET;ORAL | 019982-002 | Jul 31, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Teva Womens | ZEBETA | bisoprolol fumarate | TABLET;ORAL | 019982-001 | Jul 31, 1992 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZEBETA
See the table below for patents covering ZEBETA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Hong Kong | 39483 | PHENOXY-AMINO-PROPANOLS AND PROCESSES FOR THEIR PREPARATION | ⤷ Sign Up |
Israel | 53063 | PHENOXY-AMINO-PROPANOLS,PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | ⤷ Sign Up |
South Africa | 7706018 | ⤷ Sign Up | |
Netherlands | 7711042 | ⤷ Sign Up | |
Portugal | 67083 | PHENOXY-AMINO-PROPANOLE UND VERFAHREN ZU IHRER HERSTELLUNG | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |